Evidence map›Paper›PMID 39513103›Full record

ArticleJournal of Cancer2024

Immunofluorescence-Verified Sphingolipid Signatures Indicate Improved Prognosis in Liver Cancer Patients.

Lujuan Pan, Huijuan Huang, Pengpeng Zhang, Hua Li, Libai Lu, Mingwei Wei, Pin Zheng, Qi Wang, Junyu Guo, Yueqiu Qin

Abstract read
In one paragraph

Article in Journal of Cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lujuan PanDepartment of Gastroenterology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, China.
Huijuan HuangDepartment of General Surgery, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, China.
Pengpeng ZhangDepartment of Lung Cancer Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China.
Hua LiDepartment of General Surgery, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, China.
Libai LuGuangxi Clinical Medical Research Center for Hepatobiliary Diseases, Guangxi, China.
Mingwei WeiDepartment of General Surgery, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, China.
Pin ZhengDepartment of Gastroenterology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, China.
Qi WangDepartment of Gastroenterology, Affiliated Hospital of Jiangsu University, Jiangsu University, Zhenjiang, China.
Junyu GuoDepartment of General Surgery, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, China.
Yueqiu QinDepartment of Gastroenterology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BiomarkersHepatocellular CarcinomaImmunofluorescencePrecision immunotherapySphingolipid

Identifiers

PMID39513103
PMCPMC11540515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.